Dechra Pharmaceuticals plc Revenue and Competitors
Claim your profile
Estimated Revenue & Valuation
- Dechra Pharmaceuticals plc's estimated annual revenue is currently $286M per year.
- Dechra Pharmaceuticals plc's estimated revenue per employee is $201,000
Employee Data
- Dechra Pharmaceuticals plc has 1423 Employees.
- Dechra Pharmaceuticals plc grew their employee count by 25% last year.
Dechra Pharmaceuticals plc Competitors & Alternatives
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $9.4M | 47 | 24% | N/A | N/A |
#2 | $30.4M | 151 | 1% | N/A | N/A |
#3 | $2.7M | 33 | 10% | N/A | N/A |
#4 | $32.2M | 160 | 20% | N/A | N/A |
#5 | $29.1M | 145 | 37% | N/A | N/A |
#6 | $2.2M | 27 | 13% | N/A | N/A |
#7 | $69.1M | 344 | 0% | N/A | N/A |
#8 | $21.3M | 106 | 0% | N/A | N/A |
#9 | $12.3M | 67 | 0% | $20M | N/A |
#10 | $4.6M | 23 | -26% | N/A | N/A |
What Is Dechra Pharmaceuticals plc?
N/A
Total Funding
1423
Number of Employees
$286M
Revenue (est)
25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Dechra Pharmaceuticals plc News
2022-04-20 - Pet Veterinary Drug Market Size, Scope And Forecast ...
... Bayer AG, Merck Animal Health, Elanco Animal Health Inc., Virbac Group, Ceva, Dechra Pharmaceuticals Plc, Vetoquinol, Orion Corporation.
2022-04-13 - Dechra Pharmaceuticals (OTCMKTS:DCHPF) Sees ...
Dechra Pharmaceuticals PLC is a holding company, which engages in the veterinary pharmaceuticals and related products business.
2022-04-06 - Insiders of Dechra Pharmaceuticals PLC (LON:DPH) would have made a tidy sum
after selling UK£1.8m worth of stock at a high price
Last week, Dechra Pharmaceuticals PLC's (LON:DPH) stock jumped 4.0%, but insiders who sold UK£1.8m worth of stock in over the past year are...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $443.7M | 2140 | 13% | $4.5M |
#2 | $1006.6M | 2192 | 11% | N/A |
#3 | $1362.4M | 2967 | N/A | N/A |
#4 | $666.8M | 3175 | 0% | N/A |
#5 | $1520M | 5937 | 1% | $2.6B |